Adelman Michael 4
4 · Aptevo Therapeutics Inc. · Filed Mar 4, 2019
Insider Transaction Report
Form 4
Adelman Michael
SVP, Commercial Operations
Transactions
- Tax Payment
Common Stock
2019-03-01$1.57/sh−2,395$3,760→ 70,426 total - Exercise/Conversion
Common Stock
2019-03-01+7,318→ 72,821 total - Award
Stock Option (right to buy)
2019-02-28+67,400→ 67,400 totalExercise: $1.52Exp: 2029-02-28→ Common Stock (67,400 underlying) - Exercise/Conversion
Restricted Stock Unit
2019-03-01−7,318→ 0 total→ Common Stock (7,318 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The options vest in three approximately equal annual installments beginning on February 28, 2020.
- [F3]On March 1, 2016 the reporting person was granted 21,958 restricted stock units. 7,320 shares of common stock underlying the restricted stock units vested on each of March 1, 2017 and March 1, 2018, and the remaining 7,318 shares vested on March 1, 2019.